Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
- 1 March 2001
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 7 (3), 115-121
- https://doi.org/10.1016/s1471-4914(00)01909-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.Brain, 2000
- Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseasesImmunology Today, 2000
- Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain ReactionThe Journal of Experimental Medicine, 2000
- Axonal Pathology in Multiple Sclerosis. A Historical NoteBrain Pathology, 1999
- The genetics of multiple sclerosis. A reviewBiomedicine & Pharmacotherapy, 1999
- Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsJCI Insight, 1999
- Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the DiseaseThe Journal of Experimental Medicine, 1997
- Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.Brain, 1997
- Proinflammatory and Antiinflammatory Cytokines in Multiple Sclerosis and Central Nervous System Acquired Immunodeficiency SyndromeJournal of Immunotherapy, 1992
- Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosisJournal of the Neurological Sciences, 1983